Venous involvement in sickle cell diseases

International Journal of Clinical and Experimental Medicine

Volumn 9, Issue 6, 2016, Pages 11950-11957

  Helvaci, Mehmet Rami ^a   Gokce, Cumali ^a   Sahan, Mustafa ^a   Hakimoglu, Sedat ^a   Coskun, Mesut ^a   Gozukara, Kerem Han ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Chronic endothelial damage; Deep venous thrombosis; Sickle cell diseases; Telangiectasia; Varice

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIGITAL CLUBBING; ENDOTHELIUM INJURY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LEG ULCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIAPISM; SICKLE CELL ANEMIA; TELANGIECTASIA; VASCULAR ENDOTHELIUM;

EID: 84977597305     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
2. Helvaci MR, Kaya H, Sevinc A, Camci C. Body weight and white coat hypertension. Pak J Med Sci 2009; 25: 6: 916-921.
3. Helvaci MR, Gokce C, Davran R, Acipayam C, Akkucuk S, Ugur M. Tonsilectomy in sickle cell diseases. Int J Clin Exp Med 2015; 8: 4586-4590.
4. Helvaci MR, Gokce C, Davran R, Akkucuk S, Ugur M, Oruc C. Mortal quintet of sickle cell diseases. Int J Clin Exp Med 2015; 8: 11442-11448.
5. Helvaci MR, Gokce C, Davarci M, Sahan M, Hakimoglu S, Coskun M. Chronic endothelial inflammation and priapism in sickle cell diseases. Int J Clin Exp Med 2016; (in press).
6. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994; 84: 643-649.
7. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2010. Global initiative for chronic obstructive lung disease (GOLD).
8. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE, Corretti MC, Hassoun PM. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009; 179: 615-621.
9. Vandemergel X, Renneboog B. Prevalence, aetiologies and significance of clubbing in a department of general internal medicine. Eur J Intern Med 2008; 19: 325-329.
10. Schamroth L. Personal experience. S Afr Med J 1976; 50: 297-300.
11. Mankad VN, Williams JP, Harpen MD, Manci E, Longenecker G, Moore RB, Shah A, Yang YM, Brogdon BG. Magnetic resonance imaging of bone marrow in sickle cell disease: clinical, hematologic, and pathologic correlations. Blood 1990; 75: 274-283.
12. Helvaci MR, Aydin LY, Aydin Y. Digital clubbing may be an indicator of systemic atherosclerosis even at microvascular level. Health Med 2012; 6: 3977-3981.
13. Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014; 312: 1033-1048.
14. Helvaci MR, Aydin Y, Ayyildiz O. Hydroxyurea may prolong survival of sickle cell patients by decreasing frequency of painful crises. Health Med 2013; 7: 2327-2332.
15. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
16. Charache S, Scott JC, Charache P. “Acute chest syndrome” in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med 1979; 139: 67-69.
17. Davies SC, Luce PJ, Win AA, Riordan JF, Brozovic M. Acute chest syndrome in sickle-cell disease. Lancet 1984; 1: 36-38.
18. Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD. Healthy life expectancy in 191 countries, 1999. Lancet 2001; 357: 1685-1691.
19. Helvaci MR, Ayyildiz O, Gundogdu M. Gender differences in severity of sickle cell diseases in non-smokers. Pak J Med Sci 2013; 29: 1050-1054.
20. Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet 2015; 385: 1778-1788.
21. Schoepf D, Heun R. Alcohol dependence and physical comorbidity: increased prevalence but reduced relevance of individual comorbidities for hospital-based mortality during a 12.5-year observation period in general hospital admissions in urban North-West England. Eur Psychiatry 2015; 30: 459-468.
22. Singh G, Zhang W, Kuo YF, Sharma G. Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD. Chest 2016; 149: 905-915.
23. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482.
24. Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, Davey Smith G, Upton M, Hawthorne V, Sin DD, Man SF, Van Eeden S, Mapel DW, Vestbo J. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 627-643.
25. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med 2000; 160: 2653-2658.
26. Anthonisen NR, Connett JE, Enright PL, Manfreda J; Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-339.
27. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA; TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411-415.
28. Helvaci MR, Erden ES, Aydin LY. Atherosclerotic background of chronic obstructive pulmonary disease in sickle cell patients. Health Med 2013; 7: 484-488.
29. Helvaci MR, Aydin Y, Gundogdu M. Smoking induced atherosclerosis in cancers. Health Med 2012; 6: 3744-3749.
30. Grunberg NE, Greenwood MR, Collins F, Epstein LH, Hatsukami D, Niaura R, O’Connell K, Pomerleau OF, Ravussin E, Rolls BJ. National working conference on smoking and body weight. Task Force 1: Mechanisms relevant to the relations between cigarette smoking and body weight. Health Psychol 1992; 11: 4-9.
31. Walker JF, Collins LC, Rowell PP, Goldsmith LJ, Moffatt RJ, Stamford BA. The effect of smoking on energy expenditure and plasma catecholamine and nicotine levels during light physical activity. Nicotine Tob Res 1999; 1: 365-370.
32. Hughes JR, Hatsukami DK. Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight. J Subst Abuse 1997; 9: 151-159.
33. Miyata G, Meguid MM, Varma M, Fetissov SO, Kim HJ. Nicotine alters the usual reciprocity between meal size and meal number in female rat. Physiol Behav 2001; 74: 169-176.
34. Laaksonen M, Rahkonen O, Prattala R. Smoking status and relative weight by educational level in Finland, 1978-1995. Prev Med 1998; 27: 431-437.
35. Helvaci MR, Kaya H, Gundogdu M. Association of increased triglyceride levels in metabolic syndrome with coronary artery disease. Pak J Med Sci 2010; 26: 667-672.
36. Myers KA, Farquhar DR. The rational clinical examination. Does this patient have clubbing? JAMA 2001; 286: 341-347.
37. Toovey OT, Eisenhauer HJ. A new hypothesis on the mechanism of digital clubbing secondary to pulmonary pathologies. Med Hypotheses 2010; 75: 511-513.
38. Fomin VV, Popova EN, Burnevich EZ, Kuz-netsova AV. Hippocratic fingers: clinical importance and differential diagnosis. Klin Med (Mosk) 2007; 85: 64-68.
39. Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK. Leg ulcers in sickle cell disease. Am J Hematol 2010; 85: 831-833.
40. Trent JT, Kirsner RS. Leg ulcers in sickle cell disease. Adv Skin Wound Care 2004; 17: 410-416.
41. Gueguen A, Mahevas M, Nzouakou R, Hosseini H, Habibi A, Bachir D, Brugière P, Lionnet F, Ribei JA, Godeau B, Girot R, Ibrahima V, Calvet D, Galactéros F, Bartolucci P. Sickle-cell disease stroke throughout life: a retrospective study in an adult referral center. Am J Hematol 2014; 89: 267-272.
42. Majumdar S, Miller M, Khan M, Gordon C, Forsythe A, Smith MG, Megason G, Iyer R. Outcome of overt stroke in sickle cell anaemia, a single institution’s experience. Br J Haematol 2014; 165: 707-713.
43. Helvaci MR, Aydogan F, Sevinc A, Camci C, Dilek I. Platelet and white blood cell counts in severity of sickle cell diseases. Pren Med Argent 2014; 100: 49-56.
44. Kossorotoff M, Grevent D, de Montalembert M. Cerebral vasculopathy in pediatric sickle-cell anemia. Arch Pediatr 2014; 21: 404-414.
45. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995; 332: 1317-1322.
46. Kaminsky A, Sperling H. Diagnosis and management of priapism. Urologe A 2015; 54: 654-661.
47. Broderick GA. Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy. J Sex Med 2012; 9: 88-103.